Poly(ADP-Ribose) Polymerase Inhibitors in the Management of Ovarian Cancer: ASCO Guideline Rapid Recommendation Update
ASCO Rapid Recommendations Updates highlight revisions to select ASCO guideline recommendations as a response to the emergence of new and practice-changing data. The rapid updates are supported by an evidence review and follow the guideline development processes outlined in the ASCO Guideline Method...
Saved in:
Published in | Journal of clinical oncology Vol. 40; no. 33; pp. 3878 - 3881 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
United States
20.11.2022
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | ASCO Rapid Recommendations Updates highlight revisions to select ASCO guideline recommendations as a response to the emergence of new and practice-changing data. The rapid updates are supported by an evidence review and follow the guideline development processes outlined in the ASCO Guideline Methodology Manual. The goal of these articles is to disseminate updated recommendations, in a timely manner, to better inform health practitioners and the public on the best available cancer care options. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0732-183X 1527-7755 |
DOI: | 10.1200/jco.22.01934 |